(Q52841791)

English

Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response.

scientific article published on 14 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy response. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

1 reference

based on heuristic

inferred from title

cancer-associated fibroblast

1 reference

based on heuristic

inferred from title

author name string

Matthew David Hale

1

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

Jeremy David Hayden

2

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

Heike Irmgard Grabsch

3

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

publication date

14 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

Cellular Oncology

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

36

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

2

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

95-112

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

https://scigraph.springernature.com/pub.10.1007/s13402-013-0127-7

0 references

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Oesophageal cancer: preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Chemotherapy and surgery versus surgery alone in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Randomised trials of HIV prevention

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Palliative chemotherapy for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Palliative chemotherapy for advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Know thy neighbor: stromal cells can contribute oncogenic signals

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Tumour-stroma interactions in carcinogenesis: basic aspects and perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Cancer-associated fibroblasts and tumor growth--bystanders turning into key players

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

P53 mutations in stromal fibroblasts sensitize tumors against chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Cancer associated fibroblasts (CAFs) in tumor microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Stromal myofibroblasts are drivers of invasive cancer growth

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hallmarks of cancer: interactions with the tumor stroma.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Cancer associated fibroblasts in cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Activation of fibroblasts in cancer stroma

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Prognostic significance of fibrotic focus in invasive ductal carcinoma of the breast: a prospective observational study

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The CCN family of angiogenic regulators: the integrin connection

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Connective tissue growth factor expression in pediatric myofibroblastic tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Cell adhesion to fibronectin induces mitomycin C resistance in bladder cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through beta1 integrin-dependent activation of PI3-kinase

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Fibulins: physiological and disease perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The dual role of fibulins in tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Regulation of breast cancer response to chemotherapy by fibulin-1.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Fibulins 3 and 5 antagonize tumor angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hyaluronan in human malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFkappa B

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hepatocyte growth factor/scatter factor inhibits UVB-induced apoptosis of human keratinocytes but not of keratinocyte-derived cell lines via the phosphatidylinositol 3-kinase/AKT pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Matrix metalloproteinases: changing roles in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

New functions for the matrix metalloproteinases in cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Complex roles of tissue inhibitors of metalloproteinases in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Localization of tissue inhibitor of metalloproteinases 1 (TIMP-1) in human colorectal adenoma and adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Diverse biological functions of the SPARC family of proteins

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Secreted protein acidic and rich in cysteine-induced cellular senescence in colorectal cancers in response to irinotecan is mediated by P53.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

SPARC Inhibits Epithelial Cell Proliferation in Part through Stimulation of the Transforming Growth Factor-β–Signaling System

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Syndecans in inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

High levels of uPA and PAI-1 predict a good response to anthracyclines

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Predictive impact of urokinase-type plasminogen activator: plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Urokinase-type plasminogen activator and its inhibitor type 1 predict disease outcome and therapy response in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Systemic endocrine instigation of indolent tumor growth requires osteopontin

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Prognostic value of syndecan-1 expression in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Fibrotic focus in invasive ductal carcinoma of the breast: a histopathological prognostic parameter for tumor recurrence and tumor death within three years after the initial operation.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Stromal biology and therapy in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Mechanisms associated with cell adhesion mediated drug resistance (CAM-DR) in hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1007%2FS13402-013-0127-7

21 January 2018

Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of MMP-7 expression for response to chemotherapy and survival in patients with non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A physiological role for connective tissue growth factor in early wound healing

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Jekyll and Hyde: the role of the microenvironment on the progression of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor histology in lymph vessels and lymph nodes for the accurate prediction of outcome among breast cancer patients treated with neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in biological markers after primary chemotherapy for breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of fibronectin by normal and malignant human mammary epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of connective tissue growth factor in cartilaginous tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stromal myofibroblasts predict disease recurrence for colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Roles of the pathologist in neoadjuvant chemotherapy: evaluation of response, prognostic and predictive factors]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant Therapy for Prostate Cancer: An Oncologist's Perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the long-term survival of the patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary tumor levels of tissue inhibitor of metalloproteinases-1 are predictive of resistance to chemotherapy in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Connective tissue growth factor gene expression alters tumor progression in esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upregulation of vimentin and aberrant expression of E-cadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SPARC in cancer biology: its role in cancer progression and potential for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vimentin expression is associated with decreased survival in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Immunohistochemical study of the extracellular matrix in non-small cell lung cancer: relation to lymph node metastasis and prognosis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23494412

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13402-013-0127-7

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 May 2018

http://europepmc.org/abstract/MED/23494412

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52841791&oldid=1418093693"